Adverse drug reactions ‒ serious and life-threatening

2004 - 2026 - Current

Sally Pepper, BScPhm, RPh, Patient Safety Section, Marketed Health Products Directorate, Health Canada; [email protected]


One-time surveys

  • Antiviral drug use and potential adverse reactions (2009)
  • ADR reporting – assessing CPSP surveillance methodology (2008)

ADR Tips

CPSP Highlights

Published papers

Resource articles

Presentations

  • Does active surveillance of adverse drug reactions improve reporting? The CPSP experience.

    Grenier D, Zimmerman M. International Network of Paediatric Surveillance Units (INoPSU) Conference, Montreux, in September 2011 (oral)

  • Can active surveillance improve reporting of serious and life-threatening drug reactions? The Canadian experience

    Grenier D, Davis MA, Zimmerman M, Laffin Thibodeau M. Canadian Paediatric Society Annual Conference, Quebec City, in June 2011 (poster)

  • Can active surveillance improve reporting of serious and life-threatening adverse drug reactions? The Canadian Paediatric Surveillance Program experience

    Grenier D, Davis MA, Ugnat A-M, Zimmerman M. Laffin Thibodeau M, Quartaro A. 5th Europaediatrics, Vienna, in June 2011 (poster)

  • ¿Una vigilancia estricta puede mejorar el reporte de reacciones adversas a medicamentos?

    Grenier D, Zimmerman M. XIII Congreso Nacional de Pediatría, CoNaPeMe, Guadalajara, in May 2011 (oral)

  • Taller de vigilancia epidemiológica pediatría

    Grenier D, Mercer R. I Conferencia de Actualizatión en Pediatría – ALAPE 2011, Panama, in April 2011 (oral)

  • The power of adverse drug reaction reporting

    Zimmerman M, Rieder M. Canadian Paediatric Society Annual Conference, Victoria, in June 2008 (oral)